De-ubiquitination of SAMHD1 by USP7 promotes DNA damage repair to overcome oncogenic stress and affect chemotherapy sensitivity
Jingwei Liu,Tingting Zhou,Xiang Dong,Qiqiang Guo,Lixia Zheng,Xiaoxun Wang,Naijin Zhang,Danni Li,Ling Ren,Fei Yi,Ying Zhang,Ziwei Li,Xiwen Wang,Chengsi Deng,Chunlu Li,Hongde Xu,Yi Guan,Xiaoman Li,Yang Yu,Wendong Guo,Zhuo Wang,Bo Jiang,Xuan Wu,Ning Bai,Yanling Feng,Mengtao Ma,Qingquan Kong,Jiayi Wei,Zhenshuang Wang,Hao Li,Songming Lu,Liangzi Cao,Yutong Xiao,Xiaoyu Song,Zhenning Wang,Chengzhong Xing,Liu Cao
DOI: https://doi.org/10.1038/s41388-023-02667-w
IF: 8.756
2023-04-21
Oncogene
Abstract:Oncogenic stress induces DNA damage repair (DDR) that permits escape from mitotic catastrophe and allows early precursor lesions during the evolution of cancer. SAMHD1, a dNTPase protecting cells from viral infections, has been recently found to participate in DNA damage repair process. However, its role in tumorigenesis remains largely unknown. Here, we show that SAMHD1 is up-regulated in early-stage human carcinoma tissues and cell lines under oxidative stress or genotoxic insults. We further demonstrate that de-ubiquitinating enzyme USP7 interacts with SAMHD1 and de-ubiquitinates it at lysine 421, thus stabilizing SAMHD1 protein expression for further interaction with CtIP for DDR, which promotes tumor cell survival under genotoxic stress. Furthermore, SAMHD1 levels positively correlates with USP7 in various human carcinomas, and is associated with an unfavorable survival outcome in patients who underwent chemotherapy. Moreover, USP7 inhibitor sensitizes tumor cells to chemotherapeutic agents by decreasing SAMHD1 in vitro and in vivo. These findings suggest that de-ubiquitination of SAMHD1 by USP7 promotes DDR to overcome oncogenic stress and affect chemotherapy sensitivity.
oncology,genetics & heredity,biochemistry & molecular biology,cell biology